Emerging roles of endothelial cells in transplant rejection

Current Opinion in Immunology

Volumn 15, Issue 5, 2003, Pages 493-498

  Valujskikh, Anna ^a   Heeger, Peter S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ANTIBODY; ANTIGEN; BETA1 INTEGRIN; CD11B ANTIGEN; CD31 ANTIGEN; CD8 ANTIGEN; CD99 ANTIBODY; CD99 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CHEMOATTRACTANT; CHEMOKINE RECEPTOR CCR7; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EFOMYCIN M; FRACTALKINE; GAMMA INTERFERON; HLA ANTIBODY; LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOKINE; PAXILLIN; PHOSPHOTYROSINE; RANTES; SELECTIN ANTAGONIST; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ALLOIMMUNITY; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; CELL MEDIATED CYTOTOXICITY; CELL MIGRATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CYTOLOGY; CYTOTOXICITY; EFFECTOR CELL; ENDOTHELIUM; ENDOTHELIUM CELL; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; HOST; HUMORAL IMMUNITY; INFLAMMATION; LEUKOCYTE; LYMPH NODE; LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MECHANICS; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PARENCHYMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION; VASCULAR ENDOTHELIUM; XENOTRANSPLANTATION;

EID: 0141629554     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00110-9     Document Type: Review

References (55)

1. Picker L.J., Treer J.R., Ferguson-Darnell B., Collins P.A., Buck D., Terstappen L.W. Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. J. Immunol. 150:1993;1105-1121.
2. Sallusto F., Kremmer E., Palermo B., Hoy A., Ponath P., Qin S., Forster R., Lipp M., Lanzavecchia A. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur. J. Immunol. 29:1999;2037-2045.
3. Lakkis F.G., Arakelov A., Konieczny B.T., Inoue Y. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat. Med. 6:2000;686-688.
4. Salomon B., Bluestone J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19:2001;225-252.
5. Perez V.L., Henault L., Lichtman A.H. Endothelial antigen presentation: stimulation of previously activated but not naive TCR-transgenic mouse T cells. Cell. Immunol. 189:1998;31-40.
6. + T cells: a mechanism of immunoregulation? J. Immunol. 165:2000;4182-4189.
7. + T cells results in antigen-specific T-cell tolerance. Nat. Med. 6:2000;1348-1354.
8. + T cells. J. Immunol. 161:1998;2158-2167.
9. + T lymphocytes in a B7-dependent fashion. J. Immunol. 169:2002;6154-6161.
10. + T cells in vivo and can function as the primary targets of the alloimmune response that ultimately results in acute graft rejection.
11. + T cells. J. Immunol. 153:1994;5402-5412.
12. + T cells.
13. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science. 272:1996;60-66.
14. Schon M.P., Krahn T., Schon M., Rodriguez M.L., Antonicek H., Schultz J.E., Ludwig R.J., Zollner T.M., Bischoff E., Bremm K.D.et al. Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation. Nat. Med. 8:2002;366-372 This study characterized Efomycines, a novel family of small molecules that structurally mimic the binding sites of selectin ligands. One of these molecules, Efomycin M, was shown to reduce leukocyte adhesion and ameliorate cell infiltration and autoimmune skin lesions in a mouse model of psoriasis.
15. Nelson P.J., Krensky A.M. Chemokines, chemokine receptors, and allograft rejection. Immunity. 14:2001;377-386.
16. von Hundelshausen P., Weber K.S., Huo Y., Proudfoot A.E., Nelson P.J., Ley K., Weber C. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation. 103:2001;1772-1777.
17. + cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J. Immunol. 168:2002;6173-6180.
18. + T cells can stimulate production of various chemokines by ECs. This finding suggests a potential mechanism by which ECs can facilitate the infiltration of primed T cells into allografts.
19. Song E., Zou H., Yao Y., Proudfoot A., Antus B., Liu S., Jens L., Heemann U. Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney Int. 61:2002;676-685.
20. Stojanovic T., Bedke J., Grone H.J., Proudfoot A.E., Becker H., Markus P., Hecker M. Met-RANTES inhibition of mucosal perfusion failure in acute intestinal transplant rejection - role of endothelial-cell-leukocyte interaction. J. Vasc. Res. 39:2002;51-58.
21. Bogen S., Pak J., Garifallou M., Deng X., Muller W.A. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J. Exp. Med. 179:1994;1059-1064.
22. Muller W.A., Weigl S.A., Deng X., Phillips D.M. PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178:1993;449-460.
23. Murohara T., Delyani J.A., Albelda S.M., Lefer A.M. Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J. Immunol. 156:1996;3550-3557.
24. Vaporciyan A.A., DeLisser H.M., Yan H.C., Mendiguren I.I., Thom S.R., Jones M.L., Ward P.A., Albelda S.M. Involvement of platelet-endothelial-cell adhesion molecule 1 in neutrophil recruitment in vivo. Science. 262:1993;1580-1582.
25. 2-integrin LFA-1. In vitro experiments demonstrate the ability of JAM-1 to control transendothelial migration of T cells and neutrophils.
26. Mamdouh Z., Chen X., Pierini L.M., Maxfield F.R., Muller W.A. Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis. Nature. 421:2003;748-753 This work provides insight into the molecular basis of rapid leukocyte transmigration. The studies identify a unique EC membrane network located below the plasmalemma that permits ECs to rapidly recycle PECAM-1, thus facilitating diapedesis.
27. Schenkel A.R., Mamdouh Z., Chen X., Liebman R.M., Muller W.A. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat. Immunol. 3:2002;143-150 This study shows that the type I transmembrane protein CD99, previously detected on hematopoietic cells, is also present in tight junctions between ECs and plays a critical role in the final step of leukocyte transmigration.
28. Ensminger S.M., Spriewald B.M., Steger U., Morris P.J., Mak T.W., Wood K.J. Platelet-endothelial-cell adhesion molecule-1 (CD31) expression on donor endothelial cells attenuates the development of transplant arteriosclerosis. Transplantation. 74:2002;1267-1273 This paper addresses the role of PECAM-1 in the development of chronic vasculopathy in a mouse model of aortic allograft. Surprisingly, the absence of PECAM-1 expression on donor ECs leads to exacerbated macrophage infiltration and transplant arteriosclerosis.
29. + T cell alloactivation. J. Exp. Med. 190:1999;555-566.
30. Jutte N.H., Knoop C.J., Heijse P., Balk A.H., Mochtar B., Claas F.H., Weimar W. Human heart endothelial-cell-restricted allorecognition. Transplantation. 62:1996;403-406.
31. Meehan S.M., McCluskey R.T., Pascual M., Preffer F.I., Anderson P., Schlossman S.F., Colvin R.B. Cytotoxicity and apoptosis in human renal allografts: identification, distribution, and quantitation of cells with a cytotoxic granule protein GMP-17 (TIA-1) and cells with fragmented nuclear DNA. Lab. Invest. 76:1997;639-649.
32. Krupnick A.S., Kreisel D., Popma S.H., Balsara K.R., Szeto W.Y., Krasinskas A.M., Riha M., Wells A.D., Turka L.A., Rosengard B.R. Mechanism of T-cell-mediated endothelial apoptosis. Transplantation. 74:2002;871-876.
33. + T cells mediate graft rejection via a distinct effector pathway. Nat. Immunol. 3:2002;844-851 This paper provides evidence that inflamed host endothelium can process exogenous donor antigens and present them in the context of recipient MHC class I. Furthermore, CD8 T cells capable of recognizing the cross-presented antigen on ECs could mediate skin graft rejection.
34. Hillebrands J.L., Klatter F.A., van den Hurk B.M., Popa E.R., Nieuwenhuis P., Rozing J. Origin of neointimal endothelium and α-actin-positive smooth muscle cells in transplant arteriosclerosis. J. Clin. Invest. 107:2001;1411-1422.
35. Lagaaij E.L., Cramer-Knijnenburg G.F., van Kemenade F.J., van Es L.A., Bruijn J.A., van Krieken J.H. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet. 357:2001;33-37.
36. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J.M., Asahara T. Ischemia- and cytokine-induced mobilization of bone-marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5:1999;434-438.
37. + T cells and expression of the disease.
38. Reed E.F., Hong B., Ho E., Harris P.E., Weinberger J., Suciu-Foca N. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation. 61:1996;566-572.
39. Costa A.N., Scolari M.P., Iannelli S., Buscaroli A., D'Arcangelo G.L., Brando B., Indiveri F., Savi M., Borgnino L.C., DeSanctis L.B.et al. The presence of posttransplant HLA-specific IgG antibodies detected by enzyme-linked immunosorbent assay correlates with specific rejection pathologies. Transplantation. 63:1997;167-169.
40. Wu G.D., Jin Y.S., Salazar R., Dai W.D., Barteneva N., Barr M.L., Barsky L.W., Starnes V.A., Cramer D.V. Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: a possible injury pathway contributing to chronic allograft rejection. J. Heart Lung. Transplant. 21:2002;1174-1187.
41. Cascalho M., Platt J.L. The immunological barrier to xenotransplantation. Immunity. 14:2001;437-446.
42. Fang J.C., Kinlay S., Behrendt D., Hikita H., Witztum J.L., Selwyn A.P., Ganz P. Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation. Arterioscler. Thromb. Vasc. Biol. 22:2002;2044-2048.
43. Baldwin W.M. III, Larsen C.P., Fairchild R.L. Innate immune responses to transplants: a significant variable with cadaver donors. Immunity. 14:2001;369-376.
44. Pober J.S. Immunobiology of human vascular endothelium. Immunol. Res. 19:1999;225-232.
45. Holzknecht Z.E., Kuypers K.L., Plummer T.B., Williams J., Bustos M., Gores G.J., Brunn G.J., Platt J.L. Apoptosis and cellular activation in the pathogenesis of acute vascular rejection. Circ. Res. 91:2002;1135-1141.
46. Bian H., Reed E.F. Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: enhancement by IFN-γ and TNF-α J. Immunol. 163:1999;1010-1018.
47. Harris P.E., Bian H., Reed E.F. Induction of high affinity fibroblast growth factor receptor expression and proliferation in human endothelial cells by anti-HLA antibodies: a possible mechanism for transplant atherosclerosis. J. Immunol. 159:1997;5697-5704.
48. Jin Y.P., Singh R.P., Du Z.Y., Rajasekaran A.K., Rozengurt E., Reed E.F. Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner. J. Immunol. 168:2002;5415-5423 The paper provides novel insights into the signal transduction events leading to human EC proliferation following ligation of EC-expressed MHC class I molecules with anti-HLA antibodies.
49. Polte T.R., Hanks S.K. Complexes of focal adhesion kinase (FAK) and Crk-associated substrate (p130[Cas]) are elevated in cytoskeleton-associated fractions following adhesion and Src transformation. Requirements for Src kinase activity and FAK proline-rich motifs. J. Biol. Chem. 272:1997;5501-5509.
50. Wang N., Lee J.M., Tobiasch E., Csizmadia E., Smith N.R., Gollackes B., Robson S.C., Bach F.H., Lin Y. Induction of xenograft accommodation by modulation of elicited antibody responses. Transplantation. 74:2002;334-345 This study demonstrates that treatment of ECs with sublytic doses of xenoreactive antibodies induces expression of the protective gene heme oxygenase-1 and subsequently prevents antibody-mediated EC destruction.
51. + T cells and that this antigen expression facilitates transmigration of antigen-reactive T cells across endothelial barriers.
52. + circulating precursors: evidence for PECAM-1 involvement through Akt/PKB activation. Blood. 101:2003;186-193.
53. Irjala H., Elima K., Johansson E.L., Merinen M., Kontula K., Alanen K., Grenman R., Salmi M., Jalkanen S. The same endothelial receptor controls lymphocyte traffic both in vascular and lymphatic vessels. Eur. J. Immunol. 33:2003;815-824 This manuscript describes a novel molecule expressed on vascular endothelial cells that controls lymphocyte trafficking into secondary lymphoid organs and sites of inflammation.
54. Mazanet M.M., Hughes C.C. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J. Immunol. 169:2002;3581-3588.
55. Xu H., Yin D., Naziruddin B., Chen L., Stark A., Wei Y., Lei Y., Shen J., Logan J.S., Byrne G.W.et al. The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection. J. Immunol. 170:2003;1531-1539 This paper nicely demonstrates that xenoreactive antibodies can activate, and induce apoptosis of, ECs despite a poor ability to fix complement.